IL17RC
protein-codinginterleukin 17 receptor C, the group of Interleukin receptors
Gene summary
This gene encodes a single-pass type I membrane protein that shares similarity with the interleukin-17 receptor (IL-17RA). Unlike IL-17RA, which is predominantly expressed in hemopoietic cells, and binds with high affinity to only IL-17A, this protein is expressed in nonhemopoietic tissues, and binds both IL-17A and IL-17F with similar affinities. The proinflammatory cytokines, IL-17A and IL-17F, have been implicated in the progression of inflammatory and autoimmune diseases. Multiple alternatively spliced transcript variants encoding different isoforms have been detected for this gene, and it has been proposed that soluble, secreted proteins lacking transmembrane and intracellular domains may function as extracellular antagonists to cytokine signaling. [provided by RefSeq, Feb 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~16.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0014642
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014642
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0015279
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious
Intervention: Allergy/Immunology/Infectious
Rationale: Individuals have been described as susceptible to Candida albicansinfections, and awareness may allow early detection and early treatment of infections
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to IL17RC variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_153460.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 203 | 7 | 219 | ||
| missense | 376 | 28 | 4 | 408 | ||
| nonsense | 1 | 4 | 14 | 19 | ||
| start loss | 0 | |||||
| frameshift | 2 | 12 | 14 | |||
| splice donor/acceptor (+/-2bp) | 2 | 16 | 1 | 19 | ||
| Total | 1 | 8 | 427 | 232 | 11 | 679 |
Highest pathogenic variant AF is 0.0003079194
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_703190.2 | 19 | MANE Select | |
| Ensembl | ENSP00000384969.3 | 19 | MANE Select | |
| RefSeq | NP_001190192.2 | 18 | Standard | |
| RefSeq | NP_001190193.2 | 17 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- IL-17 signaling pathway - Homo sapiens (human)
- Cytokine-cytokine receptor interaction - Homo sapiens (human)
- IL17 signaling pathway
Biological Process
- defense response to fungus
- granulocyte chemotaxis
- interleukin-17-mediated signaling pathway
- positive regulation of cytokine production involved in inflammatory response
- positive regulation of interleukin-6 secretion
Molecular Function
- signaling receptor binding
- interleukin-17 receptor activity
Cellular Component
- plasma membrane
- cell surface
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000295981
- Coding exons
- 19
- Length
- 16557
- Individuals with no LoFs
- 124302
- Homozygous LoFs
- 10
- Heterozygous LoFs
- 1436
- Defined
- 125748
- p
- 0.00577
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0924 | 441 | 447 | 0.988 | 0.0000237 | 4973 |
| Missense (PolyPhen) | 81 | 91.844 | 0.88193 | 1166 | ||
| Synonymous | -1.26 | 224 | 201 | 1.11 | 0.0000117 | 1679 |
| Loss of Function | 2.28 | 29 | 45.6 | 0.636 | 0.00000241 | 447 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0026 | 0.0023 | notable |
| Latino/Admixed American | 0.0049 | 0.0039 | notable |
| Ashkenazi Jewish | 0.0016 | 0.00099 | notable |
| East Asian | 0.00044 | 0.00044 | rare |
| Finnish | 0.0057 | 0.0050 | notable |
| European (Non-Finnish) | 0.011 | 0.0093 | notable |
| South Asian | 0.0020 | 0.0015 | notable |
| Other | 0.011 | 0.0083 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Receptor for IL17A and IL17F homodimers as part of a heterodimeric complex with IL17RA (PubMed:16785495). Receptor for the heterodimer formed by IL17A and IL17B as part of a heterodimeric complex with IL17RA (PubMed:18684971). Has also been shown to be the cognate receptor for IL17F and to bind IL17A with high affinity without the need for IL17RA (PubMed:17911633). Activation of IL17RC leads to induction of expression of inflammatory chemokines and cytokines such as CXCL1 (PubMed:16785495). {ECO:0000269|PubMed:16785495, ECO:0000269|PubMed:17911633, ECO:0000269|PubMed:18684971}.; FUNCTION: Isoform 6: Does not bind IL17A or IL17F. {ECO:0000269|PubMed:16785495}.; FUNCTION: Isoform 8: Receptor for both IL17A and IL17F. {ECO:0000269|PubMed:16785495}.;
- Disease
- DISEASE: Candidiasis, familial, 9 (CANDF9) [MIM:616445]: A disorder characterized by altered immune responses and impaired clearance of fungal infections, selective against Candida. It is characterized by persistent and/or recurrent infections of the skin, nails and mucous membranes caused by organisms of the genus Candida, mainly Candida albicans. {ECO:0000269|PubMed:25918342}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.931
- RVIS EVS
- 2.09
- RVIS percentile EVS
- 97.87
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.252
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |